Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey

Am J Hematol. 2017 Nov;92(11):E626-E627. doi: 10.1002/ajh.24866. Epub 2017 Aug 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Dasatinib / therapeutic use
  • Female
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Male
  • Mutation*
  • Physicians*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use
  • Surveys and Questionnaires*

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • nilotinib
  • Dasatinib